News

Generic sildenafil approved for erectile dysfunction


 

References

The first generic version of sildenafil citrate has been approved for the treatment of erectile dysfunction, the Food and Drug Administration has announced.

Teva Pharmaceutical Industries received approval to market generic sildenafil citrate tablets in 25-mg, 50-mg, and 100-mg doses and has been granted 180-day exclusivity, according to the FDA.

mdales@frontlinemedcom.com

Recommended Reading

Pre-exposure prophylaxis could cut HIV incidence by 44%
MDedge Internal Medicine
Combination of celecoxib, zoledronic acid benefits some with hormone-sensitive prostate cancer
MDedge Internal Medicine
Testicular cancer patients who fare well early on have smooth sailing thereafter
MDedge Internal Medicine
Hypofractionated radiation emerges as new standard of care for prostate cancer
MDedge Internal Medicine
Enzalutamide cuts disease progression, death in CRPC
MDedge Internal Medicine
ADT resistance signature predicts failure of hormone therapy for prostate cancer
MDedge Internal Medicine
Statins don’t appear to compromise effectiveness of abiraterone
MDedge Internal Medicine
Testosterone: Moderate sexual, mood benefits; no vitality benefit
MDedge Internal Medicine
Diet, lifestyle factors add up in reducing risk of prostate cancer death
MDedge Internal Medicine
Radiotherapy for prostate cancer linked to higher risk of secondary malignancies
MDedge Internal Medicine